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Abstract
Background: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, including hyper- or hypo-activity of the stress
hormone system, plays a critical role in the pathophysiology of mood disorders such as major depression (MD). Further
biological hallmarks of MD are disturbances in circadian rhythms and sleep architecture. Applying a translational approach,
an animal model has recently been developed, focusing on the deviation in sensitivity to stressful encounters. This so-called
‘stress reactivity’ (SR) mouse model consists of three separate breeding lines selected for either high (HR), intermediate (IR),
or low (LR) corticosterone increase in response to stressors.
Methodology/Principle Findings: In order to contribute to the validation of the SR mouse model, our study combined the
analysis of behavioural and HPA axis rhythmicity with sleep-EEG recordings in the HR/IR/LR mouse lines. We found that
hyper-responsiveness to stressors was associated with psychomotor alterations (increased locomotor activity and
exploration towards the end of the resting period), resembling symptoms like restlessness, sleep continuity disturbances
and early awakenings that are commonly observed in melancholic depression. Additionally, HR mice also showed
neuroendocrine abnormalities similar to symptoms of MD patients such as reduced amplitude of the circadian
glucocorticoid rhythm and elevated trough levels. The sleep-EEG analyses, furthermore, revealed changes in rapid eye
movement (REM) and non-REM sleep as well as slow wave activity, indicative of reduced sleep efficacy and REM sleep
disinhibition in HR mice.
Conclusion/Significance: Thus, we could show that by selectively breeding mice for extremes in stress reactivity, clinically
relevant endophenotypes of MD can be modelled. Given the importance of rhythmicity and sleep disturbances as
biomarkers of MD, both animal and clinical studies on the interaction of behavioural, neuroendocrine and sleep parameters
may reveal molecular pathways that ultimately lead to the discovery of new targets for antidepressant drugs tailored to
match specific pathologies within MD.
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Introduction
The rotation of the earth exposes all organisms to a daily change
in light intensity and virtually all species have adapted their lifestyles
to cycles of 24 hours [1]. These daily rhythms are endogenously
generated and are synchronised to external time cues in order to
ensure that bodily processes are carried out at the appropriate,
optimal time of day or night [2,3]. In mammals, the suprachias-
matic nuclei in the anterior-ventral hypothalamus are the principal
oscillator coordinating many physiological and behavioural func-
tions, including the circadian rhythms of body temperature,
hormone secretion (e.g. melatonin, luteinising hormone, growth
hormone) and sleep-wake behaviour [2–4]. The activity of the
hypothalamic-pituitary-adrenal (HPA) axis isalsocharacterisedby a
prominent circadian rhythm with peak glucocorticoid (GC)
secretion occurring shortly before the onset of an animal’s activity
period and trough levels during the beginning of the resting period
[4,5]. This daily variation of GC concentration is critical for
homeostatic regulation of metabolic, cardiovascular and neural
processes, and a bidirectional interaction between sleep and the
HPA system has been well established [6–8].
Interestingly, the sleep-endocrine regulation is critically influ-
enced by brain areas, which also play an important role in the
pathophysiology of affective disorders such as major depression
(MD) [6–10]. These include the hypothalamus, particularly the
paraventricular nucleus, but also limbic areas such as the
hippocampus and the amygdala, the prefrontal cortex as well as
afferent brain nuclei, in particular the locus coeruleus and the
raphe nuclei [6–11]. Therefore, it is not surprising that sleep
disturbances are among the most common symptoms of MD
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4325[6,7,9–12]. Compared to healthy subjects, electroencephalogram
(EEG) recordings, which allow to objectively assess sleep
alterations, revealed that MD patients often suffer from insomnia
and sleep fragmentation (i.e. increased time to fall asleep, frequent
awakenings and early morning awakenings, some hours earlier
than desired, with difficulty returning to sleep). They also show a
reduced latency to the first episode of rapid eye movement (REM)
sleep, an increased proportion of REM sleep (increased REM
density and intensity) and reduced slow-wave activity (SWA)
during non-REM (NREM) sleep [6,7,11,12].
Another biological hallmark of MD is the dysregulation of the
HPA axis (hyper- or hypo-activity), largely involving pathological
alterations in the corticotrophin-releasing hormone (CRH) system
(for reviews see [6,9,10,13–20]). Therefore, sleep-EEG and stress
hormone alterations were also among the first biological changes
reported in MD [21–23]. Common neuroendocrine symptoms of
severely depressed patients include a flattened diurnal rhythm of
GC secretion (in particular, elevated trough levels have been
observed [24–27], elevated plasma and 24-h urinary GC
concentrations (hypercortisolism) and adrenal hyperplasia. Fur-
thermore, dysfunctional GC receptor-mediated negative feedback
regulation of the HPA axis and changes in vasopressin and CRH
responsiveness have frequently been described [9,13,15–20].
However, it is increasingly acknowledged that the diagnosis of
MD encompasses patients who do not necessarily share the same
disease biology, supporting the concept of different subtypes of
depression [7,10,15,17,28]. For instance, HPA axis overdrive,
related to an enhanced secretion of CRH and an impaired
negative feedback via GC receptors, is most consistently observed
in patients with melancholic depression. These patients also show
the most pronounced sleep-EEG alterations, including disrupted
sleep, decreased SWA, short REM sleep latency and high REM
sleep density. In contrast, patients presenting with the so-called
atypical subtype of depression are characterised by markedly
reduced activity of the HPA axis, while sleep-EEG data suggest
that SWA is not reduced and REM sleep parameters are not
considerably altered in these patients [7,15,17,28,29].
Based on the vital link between stress sensitivity and the
development of MD [9,13,16,18,20], a new, genetic animal model
has been recently established at the Max Planck Institute of
Psychiatry, focusing on alterations in HPA axis reactivity [30].
This so-called ‘stress reactivity’ (SR) mouse model consists of three
separate breeding lines selected for either high (HR), intermediate
(IR), or low (LR) corticosterone increase in response to a moderate
psychological stressor (15-min restraint). Significant differences in
the reactivity of the HPA axis between HR, IR and LR mice were
already found in the first generation of the selective breeding
process and proved to be a highly heritable trait, i.e. the respective
phenotype was confirmed across all subsequent generations and
could even be increased by assortative breeding [30]. Moreover,
results of an extensive behavioural test battery applied to the
selected mouse lines as well as neuroendocrine characterisation
experiments revealed several phenotypic similarities with changes
observed in depressive patients [30]. In general, HR animals were
relatively hyperactive in some behavioural paradigms, resembling
symptoms of restlessness and agitation often seen in melancholic
depression. LR mice, on the other hand, showed more passive-
aggressive coping styles, corresponding to signs of retardation and
retreat observed in atypical depression.
As outlined above, HPA axis functioning plays a critical role for
the regulation of sleep and activity rhythms. Therefore, the aim of
this study was to combine the analysis of behavioural and HPA
axis rhythmicity with sleep-EEG recordings in the HR/IR/LR
mouse lines, in order to provide a more comprehensive picture of
endophenotypes associated with increased or decreased stress
reactivity. Thus, we intended to further contribute to the
validation of the SR mouse model as a promising tool to elucidate
molecular genetic, neuroendocrine and behavioural parameters
associated with altered HPA axis reactivity.
Methods
Animals and general housing conditions
All animals used in this study derived from the seventh
generation (Gen VII) of the ‘stress reactivity’ (SR) mouse model.
As outlined above, this model consists of three independent mouse
lines selectively bred for either high (HR), intermediate (IR) or low
(LR) reactivity of the HPA axis (for a detailed description of the
model see [30]).
Details about housing conditions, age, and the number of mice
used in each experiment are given in the respective sections (see
below). In general, from weaning at the age of about four weeks all
animals were housed in same-sex groups of two to four mice in
transparent polycarbonate cages (standard Macrolon cages type
III, 38622615 cm
3) with wood chips as bedding and wood
shavings as nesting material (Product codes: LTE E-001 and NBF
E-011, ABEDD - LAB and VET Service GmbH, Vienna, Austria).
The animal housing room as well as the experimental rooms were
maintained under standard laboratory conditions (light-dark cycle:
12 : 12 h, lights on at 8 a.m.; temperature: 2261uC; relative
humidity: 55610%). Commercial mouse diet (Altromin No. 1324,
Altromin GmbH, Lage, Germany) and bottled tap water were
available ad libitum.
The presented work complies with current regulations covering
animal experimentation in Germany and the EU (European
Communities Council Directive 86/609/EEC). All experiments
were announced to the appropriate local authority and were
approved by the ‘Animal Welfare Officer’ of the Max Planck
Institute of Psychiatry (Az. 55.2-1-54-2531-64-07 and Az. 209.1/
211-33/04).
Stress reactivity testing and selection of experimental
animals
Routinely, all animals of each breeding generation of the SR
mouse model are subjected to a so-called ‘stress reactivity test’
(SRT) performed at around eight weeks of age. Details about the
test procedure and subsequent analyses are described by Touma
and colleagues [30]. Briefly, the SRT consists of a 15-min restraint
period and two tail blood samplings immediately before and after
exposure to the stressor. All animals are tested in the first hours of
the light phase (between 9 a.m. and 11 a.m.), i.e. during the trough
of the circadian rhythm of GC secretion. From the collected
‘initial’ and ‘reaction’ blood samples, corticosterone concentra-
tions are determined by radioimmunoassay, quantifying the
reactivity of the HPA axis as corticosterone increase in response
to a moderate psychological stressor.
According to the outcome of this SRT, 36 male mice (12 of each
breeding line) of Gen VII were selected as experimental animals,
showing a high, intermediate or low corticosterone increase,
characteristic of the neuroendocrine stress response phenotype of
the HR, IR and LR breeding line, respectively [30].
Behavioural activity rhythms
To monitor the undisturbed behavioural activity rhythm of the
animals, we used a self-made device (‘System for Automatic
Measurement of Laboratory Animals’ Behaviour’ SAMLAB)t o
automatically track resting versus motor activity, explorative
behaviours as well as feeding and drinking activities in the home
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frames equipped with 48 infrared light barriers (32616 photo
electric sensors) positioned at a distance of about 1 cm around
each cage (standard Macrolon cage type III with a special bedding
material: Rehofix maize granulate, MK 2000, round particle size:
1.7–2.2 mm, absorption capacity: 2.0 l/kg), with the first frame 3
cm above ground level and the other 5 cm higher. Thereby, the
cage floor as well as the upper level of the cage were divided into a
grid of 1.2561.5 cm
2, enabling the detection of the position of the
mouse and the calculation of its movements according to light
beam breaks using a customized software (construction and
programming of SAMLAB by Oleg Dolgov). Motor activity was
defined as non-resting, i.e. when the mouse was moving and
activating changing sets of light barriers. Explorative behaviours
such as rearing and climbing on the cage lid could also be
detected, i.e. when the mouse activated light barriers at the ground
and upper level simultaneously (rearing) or only showed
movement in the upper grid of light barriers (climbing). In order
to avoid potentially confounding influences of human activities in
the housing room on the animals activity rhythm, the whole
activity monitoring setup was built into a soundproof cabinet
equipped with an autonomic ventilation, temperature, humidity
and light control system (set to the same conditions as in the
housing room; see above). Glass doors allowed inspections of the
test animals without disturbing the measurements.
Each mouse (12 HR, IR and LR males, respectively, about
10 weeks of age; see above) was single housed for at least two
weeks before being put into the activity monitoring device and was
kept in the light barrier monitored cages for one week with
minimal disturbance from outside. The first three days in the
apparatus were regarded as a habituation period and, therefore,
only the data of the last four days were analysed. The ‘time spent
active’ (motor activity and explorative behaviours; see definitions
above) was continuously recorded during the entire 24-hour light-
dark cycle and was averaged for each individual in hourly intervals
over the four recording days, resulting in a mean activity pattern
for each mouse.
Diurnal rhythm of glucocorticoid secretion
In order to accurately follow the natural diurnal rhythm of
glucocorticoid secretion in HR, IR and LR mice without
interfering with the activation of the HPA axis by repeated
handling and blood sampling, a non-invasive technique to monitor
adrenocortical activity by measuring corticosterone metabolites
(CM) in the faeces of mice was applied [31,32]. This technique of
glucocorticoid metabolite quantification in faecal samples has been
established in a large number of species (for review see [33]) and
has been extensively validated for laboratory mice [31,32].
T h es a m e3 6H R / I R / L Rm a l e s( 1 2o fe a c hb r e e d i n gl i n e )t h a t
were characterised with respect to their behavioural activity rhythms
(see above) were also used in this experiment (after two weeks of
normal housing in standard cages). For a period of 48 hours, faecal
samples were collected quantitatively in short sampling intervals of
two hours and stored at 220uC until analysis of CM (see below). To
facilitate individual sampling and quantitative collection of all voided
faeces without handling the animal, the method described by Touma
and colleagues was used [31,32]. Briefly, the mice were housed
individually in stainless steel wire cages (38622615 cm
3), which were
placed in standard Macrolon cages of the same size. All excreta
dropped through the bars of the wire cage and could easily be
collected from the floor of the lower cage, which was completely
covered with filter paper that immediately absorbed the urine. To
habituate the mice to this sampling procedure and to being housed in
wire cages, the animals were already placed into this housing system
three days prior to the beginning of the experiment and samples were
collected in 12 hour intervals during this time. Since mice are
nocturnal animals and their steroid excretion pattern is known to be
influenced by their activity [32], all sample collections performed
during the dark phase of the light-dark cycle were conducted under
dimmed lighting conditions (less than 5 lux) to avoid disturbing the
animals’ natural activity pattern.
The collected faecal samples were analyzed for immunoreactive
CM using a 5a-pregnane-3b,11b,21-triol-20-one enzyme-immu-
noassay (EIA). Details regarding development, biochemical
characteristics, and biological validation of this assay are described
by Touma and colleagues [31,32]. Before EIA analysis, the faecal
samples were homogenized and aliquots of 0.05 g were extracted
with 1 ml of 80% methanol. A detailed description of the assay
performance has been published elsewhere [32]. Briefly, the EIA
used a double-antibody technique and was performed on anti-
rabbit-IgG-coated microtitre plates. After overnight incubation (at
4uC) of standards (range: 0.8–200 pg/well) and samples with
steroid antibody and biotinylated label, the plates were emptied,
washed and blotted dry, before a streptavidin horseradish
peroxidase conjugate was added. After 45 minutes incubation
time, plates were emptied, washed, and blotted dry. The substrate
(tetramethylbenzidine) was added and incubated for another
45 minutes at 4uC before the enzymatic reaction was stopped with
1 mol/l sulphuric acid. Then, the optical density (at 450 nm) was
recorded with an automatic plate reader and the hormone
concentrations were calculated. The intra- and inter-assay
coefficients of variation were 8.8% and 13.4%, respectively.
For each individual, CM concentrations of the two correspond-
ing sampling intervals during the 48 hour sampling period were
averaged, yielding a mean diurnal pattern of glucocorticoid
secretion for each mouse.
Sleep recordings
To study the sleep patterns and quality of HR, IR and LR mice,
EEG recordings were performed with a subset of animals (N=8
males per line) from the experiments described above. All animals
werehoused individuallyincustomized recordingcages (26626635
cm
3) located in sound-attenuated chambers kept at constant
laboratory conditions (22uC 61uC, 12 : 12 h light-dark cycles,
lights on at 10 a.m.). Food and water were available ad libitum.
Surgical procedures were performed under isoflurane/oxygen
anaesthesia using a custom-made vaporizing device. At the
beginning of the surgery, each animal also received atropinesulfate
(0.05 mg/kg BW) and meloxicam (0.5 mg/kg BW) subcutaneously
for cardiovascular stabilisation and analgesia, respectively. The
animals were positioned in a stereotactic frame and four epidural
EEG and two intramuscular electromyogram (EMG) electrodes
were implanted. Briefly, the skin and muscles overlaying the skull
were cut rostro-caudally along the midline, drawn to the sides and
kept in place using small retractors. To insert the EEG electrodes,
four small holes (diameter: 200 mm) were drilled into the skull.
Two electrodes were placed bilaterally at the frontal region of the
cortex, one reference-electrode was placed at the right parietal
area, and the ground electrode was inserted at the left parietal
area. All four electrodes were fixed with dental cement to the skull.
Additionally, two bilateral EMG electrodes were embedded
laterally of the spine into the neck muscles. All electrodes were
composed of gold wire with ball-shaped endings, soldered to a
small standard printed circuit board connector. In order to
provide more stability to the assembly on the skull for chronic
recording, two additional small holes were drilled for mounting
jeweller’s screws that were also framed with dental cement and
glued together with the electrodes and the connector.
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in the recording cages before two successive 23-hour recording
sessions of EEG and EMG signals were performed. During
recovery and recording each mouse was attached to a recording
cable, which was connected to a swivel system allowing relatively
free movement of the animals.
EEG and EMG signals were fed online into a preamplifier
(10006, custom made) and a main amplifier (106, custom made).
The EEG signals were analogue band-pass filtered (0.5–29 Hz,
filter frequency roll off 48 dB/octave) and digitized at a sampling
rate of 64 Hz (AD board, NI PCI-6070, National Instruments,
Austin, USA). Root mean square was applied to all non-filtered
EMG signals before its digital conversion (64 Hz). The vigilance
states ‘wake’, ‘non-rapid eye movement sleep’ (NREM sleep) and
‘rapid eye movement sleep’ (REM sleep) were scored on a
LabVIEW-based scoring program (SEA, Ko ¨ln, Germany) semi-
automatically with a Fast Fourier Transformation algorithm
spectral analysis and could be corrected manually, if necessary
(the scoring technique was validated beforehand). The frequency
bands were as follows: d (0.5–5 Hz), h (6–9 Hz), a (10–15 Hz), g
(16–22.5 Hz) and b (23–31.75 Hz). A detailed description of the
scoring procedure is described elsewhere [34]. Slow wave activity
(SWA, NREM sleep frequency bands: 0.5–15 Hz; SWA frequency
bands: 0.5–4 Hz in 0.5 Hz steps) was calculated from the total
amount of NREM sleep across the 23-hour recording time in one
hour means.
Statistical Analysis
Since a normal distribution and variance homogeneity of the
data could not always be assumed, analyses were exclusively
performed using non-parametric statistics [35]. All tests were
applied two-tailed and were calculated using the software package
SPSS (version 16.0). ANOVA on ranks (Friedman-test) was used to
evaluate differences between more than two dependent (related)
samples. Two independent samples were compared using the
Mann-Whitney U-test (MWU-test), while differences between
more than two independent samples were calculated with the
Kruskal-Wallis H-test (KWH-test). In the case of significant
variation proved by the KWH-test, post-hoc pairwise comparisons
between the groups were done using multiple MWU-tests.
Spearman’s rank-order correlation was calculated to elucidate
the degree of association between two variables. As nominal level
of significance a=0.05 was accepted and corrected for post-hoc
tests according to the sequential Bonferroni technique [36].
Results
HPA axis reactivity
As expected, the experimental animals selected from generation
VII of the HR, IR and LR breeding lines differed significantly
regarding their corticosterone increase in the SRT (KWH-test:
N=12 for each line, H=31.1, df=2, p,0.001; see Fig. 1). HR
mice showed a very much exaggerated stress response, while
compared to IR animals the secretion of corticosterone was
strongly reduced in LR mice (see Fig. 1).
Behavioural activity rhythms
The behavioural activity rhythms also differed significantly
between the three breeding lines. Although a clear pattern of
increased motor activity during the dark phase and less activity
during the light phase could be observed in all mouse lines
(Friedman-tests: N=12 for each line, Chir
2=134.1–142.7,
Figure 1. Corticosterone increase in the stress reactivity test (SRT) of the experimental animals selected from the seventh
generation of the high (HR), intermediate (IR) and low (LR) reactivity mouse lines. Data are given as box plots showing medians (lines in
the boxes), 25% and 75% percentiles (boxes) as well as 10% and 90% percentiles (whiskers). Statistical differences between the three lines (KWH-test,
for details see text) are given at the top of the panel and results of the pairwise group comparisons (post-hoc MWU-tests) are indicated below
(Bonferroni corrected p,0.001 ***).
doi:10.1371/journal.pone.0004325.g001
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24-hour light-dark cycle significant differences in motor activity
were found between HR, IR and LR animals (KWH-tests: N=12
for each line, experimental time points: 4, 7, 8, 9, 16, 20, H=6.4–
8.9, df=2, all p,0.05; see Fig. 2). In particular, in the second half
of the light phase, i.e. some hours before the light-dark transition,
HR mice were clearly more active than IR and LR mice, while the
latter did not differ significantly from each other in their overall
activity pattern (see Fig. 2).
A similar picture emerged for the distribution of explorative
behaviours such as rearing and climbing. Again, all three mouse
lines showed a significant variation over the day regarding the time
spent exploring the cage (Friedman-tests: N=12 for each line,
Chir
2=135.5–149.5, df=23, all p,0.001; see Fig. 3). However,
the increase of explorative activities shortly before the light-dark
transition was much more pronounced and advanced by some
hours in HR mice compared to the other two lines, resulting in
significant differences at several time points during the light phase
(KWH-tests: N=12 for each line, experimental time points: 6, 7,
8, 9, 10, H=6.1–12.6, df=2, all p,0.05; see Fig. 3).
Diurnal rhythm of glucocorticoid secretion
Regarding the diurnal rhythm of glucocorticoid secretion, all
three mouse lines showed a significant variation of CM
concentrations over the 24-hour light-dark cycle (Friedman-tests:
N=12 for each line, Chir
2=100.9–110.5, df=12, all p,0.001;
see Fig. 4). Overall, highest concentrations were measured during
the dark phase (peaking around midnight), while relatively low
CM levels were observed during the light phase. Comparing the
concentrations of excreted CM between HR, IR and LR animals
across the day, however, revealed significant differences at several
sampling time points during the light as well as during the dark
phase (KWH-tests: N=12 for each line, experimental time points:
0, 2, 4, 6, 8, 10, 20, 24, H=8.4–18.2, df=2, all p,0.05; see Fig. 4).
In general, HR mice showed distinctly and significantly higher
CM concentrations than IR and LR animals, in particular during
the light phase, but not so much at the beginning of the dark phase
(see Fig. 4), resulting in a flattened diurnal rhythm of CM
excretion (difference between the maximum and minimum CM
concentration across the day=Delta means: HR=53.4,
IR=69.9, LR=68.2, KWH-test: N=12 for each line, H=7.5,
df=2, p,0.05). Furthermore, the area under the curve (AUC) and
the mean location (ML) of CM concentrations was significantly
higher in HR animals compared to the other two lines, which did
not differ significantly from each other (AUC means:
HR=1678.3, IR=1280.1, LR=1133.5; ML means: HR=68.9,
IR=52.2, LR=46.1; KWH-tests: N=12 for each line, H=8.2
and 8.4, df=2, both p,0.05).
Sleep recordings
The results of the sleep recording experiment are presented in
figure 5. Similar to the behavioural activity patterns described
above, the distribution of wakefulness and sleep varied significantly
during the course of the day in all three mouse lines, with a larger
amount of time spent sleeping in the light phase than in the dark
phase. However, at several time points across the light-dark cycle,
the relative amount of time the animals spent in either vigilance
state (wake, NREM sleep or REM sleep) differed significantly
between HR, IR and LR mice.
The amount of wakefulness was higher in HR mice during the
second half of the light phase, but significant effects were also
found at the end of the dark phase (KWH-tests: N=8 for each
line, experimental time points: 7, 12, 23, H=6.0–8.4, df=2, all
p,0.05; see Fig. 5A). Similarly, the lines differed significantly in
the total amount of NREM sleep (KWH-tests: N=8 for each line,
experimental time points: 7, 12, 14, H=6.2–9.9, df=2, all
Figure 2. Distribution of motor activity over the 24-h light-dark cycle in high (HR), intermediate (IR), and low (LR) reactivity males
from generation VII. Data are given as means6SEM for each line. Statistical differences between the three lines are indicated by asterisks (KWH-
tests, for details see text, p,0.05 *). The dark phase of the light-dark cycle is indicated by the shaded area.
doi:10.1371/journal.pone.0004325.g002
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PLoS ONE | www.plosone.org 5 January 2009 | Volume 4 | Issue 1 | e4325Figure 3. Distribution of explorative behaviour over the 24-h light-dark cycle in high (HR), intermediate (IR), and low (LR) reactivity
males from generation VII. Data are given as means6SEM for each line. Statistical differences between the three lines are indicated by asterisks
(KWH-tests, for details see text, p,0.05 *, p,0.01 **). The dark phase of the light-dark cycle is indicated by the shaded area.
doi:10.1371/journal.pone.0004325.g003
Figure 4. Diurnal variation of immunoreactive corticosterone metabolites (CM) in faecal samples of high (HR), intermediate (IR),
and low (LR) reactivity males from generation VII over the 24-h light-dark cycle. Data are given as means6SEM for each line. Statistical
differences between the three lines are indicated by asterisks (KWH-tests, for details see text, p,0.05 *, p,0.01 **, p,0.001 ***). The dark phase of
the light-dark cycle is indicated by the shaded area.
doi:10.1371/journal.pone.0004325.g004
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HR mice spent less time in NREM sleep than LR mice (MWU-
tests: N=8 for each line, experimental time points: 7, 12, U=6–
10, all Bonferroni corrected p,0.05; see Fig. 5B). The most
pronounced differences between the three lines, however, were
found regarding the amount of REM sleep (KWH-tests: N=8 for
each line, experimental time points: 1, 4, 6, 8, 9, 21, 23, H=8.4–
15.8, df=2, all p,0.05; see Fig. 5C). During the majority of time
points in the light phase as well as towards the end of the dark
phase, HR mice spent much more time in REM sleep than LR
(MWU-tests: N=8 for each line, experimental time points: 1, 4, 6,
8, 9, 21, 23, U=0–8, all Bonferroni corrected p,0.05; see Fig. 5C)
and IR animals (MWU-tests: N=8 for each line, experimental
time points: 1, 4, 9, 21, 23, U=1–10, all Bonferroni corrected
p,0.05; see Fig. 5C).
Focusing on the SWA within NREM sleep episodes also
revealed distinct differences between the three mouse lines at
virtually every time point across the light-dark cycle (KWH-tests:
N=8 for each line, experimental time points: 1, 2, 3, 4, 5, 6, 7, 8,
9, 10, 11, 12, 13, 15, 16, 17, 18, 19, 20, 21, 22, 23, H=4.6–15.0,
df=2, all p,0.05; see Fig. 6). Post-hoc tests confirmed that HR
mice showed a clearly and significantly decreased SWA,
particularly when compared to LR males (MWU-tests: N=8 for
each line, experimental time points: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,
13, 15, 16, 17, 19, 20, 21, 23, U=0–5, all Bonferroni corrected
p,0.05, experimental time points: 2, 18, 22, U=6–8, all
Bonferroni corrected p,0.1; see Fig. 6), but also in comparison
to IR animals (MWU-tests: N=8 for each line, experimental time
points: 1, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 17, 20, 21, 22, 23, U=0–13,
all Bonferroni corrected p,0.05, experimental time points: 15, 16,
18, 19, U=8–14, all Bonferroni corrected p,0.1; see Fig. 6). At
some experimental time points, the amount of SWA was also
significantly higher in LR than in IR animals (MWU-tests: N=8
for each line, experimental time points: 13, 19, 20, 21, U=2–8, all
Bonferroni corrected p,0.05, experimental time point: 12,
U=12, Bonferroni corrected p,0.1; see Fig. 6).
Correlation analysis further revealed in HR mice significant
associations between stress reactivity (corticosterone increase in the
Figure 5. Distribution of vigilance states over the 24-h light-
dark cycle in high (HR), intermediate (IR), and low (LR)
reactivity males from generation VII. The relative amount of
wakefulness, non-rapid eye movement (NREM) sleep and rapid eye
movement (REM) sleep are plotted in panel A, B and C, respectively.
Data are given as means6SEM for HR and LR mice and as SEM-area for
the IR mouse line. Statistical differences between the three lines are
indicated by asterisks (KWH-tests, for details see text, p,0.05 *). The
dark phase of the light-dark cycle is indicated by the shaded area.
doi:10.1371/journal.pone.0004325.g005
Figure 6. Distribution of the relative amount of slow wave
activity (SWA) over the 24-h light-dark cycle in high (HR),
intermediate (IR), and low (LR) reactivity males from genera-
tion VII. Data are given as means6SEM for HR and LR mice and as
SEM-area for the IR mouse line. Statistical differences between the three
lines are indicated by asterisks (KWH-tests, for details see text, p,0.05
*). The dark phase of the light-dark cycle is indicated by the shaded
area.
doi:10.1371/journal.pone.0004325.g006
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corrected p,0.01), the proportion of REM sleep (rs=0.810,
Bonferroni corrected p,0.05) and the amount of SWA
(rs=20.738, Bonferroni corrected p,0.05) across the day. That
is, animals with a greater corticosterone response in the SRT
showed a higher CM excretion profile, a greater increase in REM
sleep and a stronger decrease in SWA. For IR and LR animals,
however, no such correlations were found.
Discussion
Clinical studies provide clear evidence for a critical role of
circadian rhythm and sleep disturbances in the pathophysiology of
mood disorders, which are also closely linked to another biological
marker of MD, the dysregulation of the HPA axis (for reviews see
[6,9,10,13–20]. Applying a selective breeding approach, we
developed an animal model that resembles the deviation in
sensitivity to stressful encounters [30]. The aim of the present
study was to investigate this ‘stress reactivity’ mouse model with
respect to the clinically relevant endophenotypes of rhythmicity
and sleep disturbances.
We found significant differences between HR, IR and LR mice
regarding their circadian rhythm of psychomotor activity and GC
secretion as well as pronounced alterations in their sleep-EEG
profiles. HR mice for instance showed increased wakefulness,
locomotor activity and exploratory behaviours towards the end of
the resting period. Moreover, the amplitude of the circadian GC
rhythm was reduced due to elevated trough levels and the
proportion of REM sleep was clearly increased in these animals.
NREM sleep and SWA on the other hand were reduced in
comparison to the other two lines. No major rhythmicity
differences were found between IR and LR mice, except for a
significantly higher proportion of slow wave sleep across the day in
LR animals.
In the experiments addressing the behavioural activity rhythms
of the animals our results revealed significant differences in the
diurnal activity patterns of the three mouse lines. In general, as
expected for nocturnal rodents, all animals were more active
during the dark phase than during the light phase, but compared
to the other two lines, HR mice showed a marked increase in
activity towards the end of the light phase, i.e. some hours before
the light-dark transition. This increased psychomotor activity
during the resting period was found in the analysis of locomotion
(see Fig. 2) as well as exploratory behaviours (see Fig. 3) and can be
interpreted as resembling the symptoms of sleep fragmentation
and early morning awakenings often seen in melancholically
depressed patients [6,7,12]. This interpretation is also supported
by our sleep-EEG data, including a detailed event related analysis
(see discussion below). The fact that LR mice did not differ
considerably from IR animals with respect to their behavioural
activity rhythm is also in accordance with clinical findings, as MD
patients with atypical features are not reported to suffer from sleep
continuity disturbances or restlessness [7,37].
Concerning the diurnal variation of HPA axis activity, i.e. the
circadian rhythm of GC secretion, similar differences between the
three mouse lines were found, as observed for the behavioural
rhythms. Again, a clear pattern of increased GC concentrations
(measured as faecal CM) during the activity period and relatively
low levels during the resting period (including a trough at the
beginning of the light phase) were observed in all animals (see
Fig. 4). This typical cycle of nadir and peak concentrations is very
much in accordance with published data on laboratory rats
(plasma samples [38,39]; faecal samples [40]) and mice (plasma
samples [41–43]; faecal samples [31,44,45]). However, compared
to the other two lines, HR mice showed clearly elevated
concentrations of faecal CM during the entire light phase as well
as at the end of the dark phase, resulting in a markedly flattened
diurnal rhythm (see Fig. 4). IR and LR mice, on the other hand,
did not differ very much, although LR animals tended to have
lower CM levels across the 24-h light-dark cycle (see Fig. 4). These
findings further support the close association between HPA axis
activity/reactivity and disturbances of neuroendocrine rhythms, as
for example very similar alterations, including a reduced
amplitude in circadian cortisol secretion patterns, elevated trough
cortisol levels and increased 24-h means, have been found in
patients suffering from melancholic or psychotic depression, both
of which are characterized by a strong increase in HPA axis drive
[24–27]. Interestingly, data available for atypical depression
suggest no change or a slight decrease in trough cortisol levels
[7], indicating similarities with the phenotype observed in the LR
mouse line (see also [30]). Although our findings match reasonably
with these clinical observations, it should be highlighted that in
rodents, the entire human syndrome of MD cannot be modelled,
but they may share core symptoms of the disease, including the
molecular pathways underlying key endophenotypes.
Potential mechanisms that might be involved in bringing about
the described alterations in the circadian GC rhythm of our mouse
lines include variations in the activity of neural networks
(assessable as brain glucose metabolism differences across times
of day) as well as abnormal levels or patterns of noradrenalin and
melatonin secretion [6–8,12]. Furthermore, neurodegenerative
processes, particularly in structures participating in the regulation
of the HPA axis such as the hippocampus, might be an important
factor, as similar disturbances in the diurnal variation of GC have
been reported in Alzheimer’s and Parkinson’s disease patients as
well as in experimental models of prion disease [45–48]. The
deterioration of the circadian rhythm is interestingly often
observed before other clinical symptoms are manifested and can
be indicative of a relapse in the case of MD. Therefore alterations
of the circadian rhythm appear to be closely linked to the body’s
stress system and might have a significant impact for a number of
pathologies, including MD (for reviews see [16,49,50]).
Genotyping efforts as well as studies addressing changes in brain
neurotransmitter and neuromodulator systems (including CRH,
serotonin and noradrenalin) are currently underway, shedding
light on the molecular underpinnings of the endophenotypes
observed in the HR/IR/LR mouse lines. Potentially, this pre-
clinical research will also yield novel insights into the fundamental
mechanisms involved in the pathophysiology of human diseases.
As outlined above, sleep abnormalities are very common
symptoms of MD patients and have been in the focus of
researchers for several decades (for reviews see [6,7,12,51–54]).
Sleep is typically divided into NREM sleep and REM sleep
episodes; the former can be further subdivided into sleep stages I–
IV in humans. Stage I sleep, the transition from wakefulness with
its mixed frequency activity and dominant alpha waves (8–12 Hz)
to shallow sleep, is marked with dominant EEG frequencies of 4–7
Hz (theta waves). Sleep spindles with frequencies of 12–15 Hz and
K-complexes are hallmarks of stage II sleep [55]. In sleep stage III,
delta waves with a frequency of around 1-3(4) Hz, so-called SWA,
are present and become increasingly dominant in stage IV sleep
(referred to as slow wave sleep). REM sleep on the other hand is
characterised by a desynchronised EEG (similar to wakefulness)
and episodic erratic movements of the eyes together with low
amplitude electromyogram activity [55].
In healthy adults, NREM sleep and REM sleep normally
alternate periodically through the night starting with around 90
min of NREM sleep, followed by a short REM sleep period of
Rhythmicity & HPA Reactivity
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during the night, with decreasing portions of sleep stages III and
IV and increasing durations of the successive REM sleep periods
towards the end of the night [56]. In depressed patients, however,
increased stage I sleep, decreased stage III and stage IV sleep,
shorter NREM sleep duration, insomnia (involving difficulties
falling asleep, sleep fragmentation and early morning awakenings)
are often reported [52,53,57,58]. In addition, common sleep-EEG
alterations include decreased REM sleep latency, increased REM
density [59,60] and increased total time spent in REM sleep [61].
It has to be noted, however, that these sleep alterations are not
uniformly found across all MD patients. In particular, when the
different subtypes of melancholic and atypical depression are
considered, the emerging picture is different. Melancholic
depression, for instance, is characterised by the aforementioned
alterations, including poor sleep quality and decreased amounts of
sleep, whereas in atypical depression poor sleep quality is rather
associated with an overall increased amount of sleep and fatigue-
like behaviour during the day [7,15,37].
Interestingly, our findings from the sleep-EEG recordings in
HR, IR and LR mice also support this dichotomy of symptom
clusters linked with diametral differences in HPA axis reactivity.
HR mice were found to have more bouts of wakefulness during the
normal resting period of the animals (see Fig. 2 and Fig. 5A) and
also showed a significant reduction in the amount of NREM sleep
at several experimental time points (see Fig. 5B). An extensive
event related analysis (applying the ‘event-history-analysis pro-
gram’ developed by Alexander Yassouridis [62]) additionally
supports the notion of a shallower and more fragmented sleep in
HR mice, as the number of awakenings and stage shifts,
particularly from REM sleep to wake, was clearly increased
during the light as well as during the dark phase in this mouse line
(Fenzl and Touma et al., in preparation). These differences in sleep
architecture might be attributed to the increased activation of the
HPA axis across the day in the HR mouse line (see discussion
above and Fig. 4). CRH is known to impair sleep and enhance
vigilance, thereby suggesting a causal relationship between shallow
sleep and the hyperactivity of the HPA system in melancholic
depression [6–8,15,51]. Other preclinical studies also support this
view. In rats, after intracerebroventricular administration of CRH,
waking was enhanced, whereas alpha-helical CRH (a specific
CRH receptor antagonist) reduced spontaneous waking [51,63].
The most pronounced differences between HR, IR and LR
mice, however, were found regarding the amount of REM sleep.
At the majority of time points during the animals’ normal resting
period, HR mice spent much more time in REM sleep than the
other two lines (see Fig. 5C). Human sleep data suggest that
changes in REM sleep, mediated by the noradrenergic, seroto-
nergic and cholinergic systems, are not only a consequence of
depression, but can be seen as true endophenotype of the disease
(reviewed in [64]). Interestingly, in a transgenic mouse model
overexpressing CRH in the entire brain, REM sleep was also
significantly enhanced [65], along with a clearly increased
responsiveness of the HPA axis to stressors and alterations in
emotional behaviour [66], hence largely overlapping with our
observations in HR mice (see also [30]). Other animal studies as
well as clinical findings further support the notion that CRH
promotes REM sleep [6,67,68], although the effect of CRH on
REM sleep seems to be site- and dose-dependent [8]. Moreover,
our findings are in line with results of sleep investigations
performed in different animal models of depression such as
exposure to chronic unpredictable stress [69] and selection for
increased ‘helplessness’ in the tail suspension test [70,71]. These
studies revealed very similar alterations in sleep/wake patterns,
distribution of sleep stages and facilitation of REM sleep as we saw
in the HR mouse line, again underlining the significant impact of
stress responsiveness on sleep architecture.
In similarity to REM sleep, significant differences between HR,
IR and LR mice were found in the proportion of slow wave sleep.
Virtually across the entire light-dark cycle, HR mice showed a
dramatically lowered level of SWA, while higher SWA was
observed in LR animals (see Fig. 6). Sleep deprivation studies
indicate that SWA reflects sleep intensity, as it was clearly
increased as a function of waking [72]. In other words, SWA can
serve as a distinct marker for homeostatic sleep pressure [73]. The
regulation of SWA itself was proposed to be a function of the ‘Two
Process Model’ [74], depending on the interaction of processes S
(sleep dependent) and C (circadian). Sleep propensity, increasingly
depending on extended time spent awake, is reflected by process S.
In this model, the sleep intensity (process S) is at its maximum at
sleep onset, declining during consecutive sleep. It is beyond the
scope of this study to reveal whether the decreased amounts of
NREM sleep can be attributed to attenuated levels of SWA, but
this would implicate that reduced SWA is an intrinsic sleep-
physiological feature of the HR mouse line, which might be
brought about by a chronic activation of the CRH system [6,75].
Interestingly, clinical studies also report a reduction in SWA in
depressed patients [6,7,11,12,76], although slow wave sleep is not
reduced and REM sleep parameters seem to be less consistently
altered in patients with atypical depression [7,17].
Taken together, our study provides clear evidence for a critical
interaction between HPA axis dysregulation and rhythmicity
disturbances, including changes in behavioural activity patterns,
circadian GC secretion and sleep architecture. In our mouse model,
hyper-responsiveness to stressors was associated with psychomotor
activity alterations, resembling the restlessness, sleep discontinuity
and early awakenings commonly observed in melancholic depres-
sion. Furthermore, HR mice also showed neuroendocrine abnor-
malities such as reduced amplitude of the circadian GC rhythm and
elevated trough levels, potentially mimicking similar symptoms in
MD patients. The sleep-EEG analyses revealed changes in NREM
and REM sleep as well as SWA in HR mice, indicative of reduced
sleep efficacy and REM disinhibition, which reasonably overlap
with observations in melancholically depressed patients. Thus, by
selectively breeding mice for extremes in stress reactivity, clinically
relevant endophenotypes of MD can be modelled, presumably
including the symptomatology and pathophysiology of specific
subtypes of depression.
It should be emphasized, however, that animal models will only
be able to mimic certain aspects of the human disease biology
rather than the entire clinical syndrome and that not all features of
our SR model match with findings in MD patients. Limitations to
the clinical relevance of the HR/IR/LR mouse lines for instance
include that HPA axis dysregulation is currently not one of the
critical diagnostic criteria for MD and that it is a genetic model,
i.e. the differences in stress responsiveness are already present early
in life, thereby potentially influencing developmental processes
that shape the respective endophenotypes. On the other hand, also
in humans, the latter mechanisms (driven by both genetic and
environmental factors) might represent key variables underlying
individual vulnerability to psychiatric disorders [9,16,77,78].
Therefore, we are convinced that elucidating similar aspects of
biological alterations in animal models and human patients can be
a major progress and that translational approaches using
appropriate animal models can substantially further our under-
standing of how organisms respond to stress and the nature of
inter-individual differences in the stress response. Given the
importance of rhythmicity and sleep disturbances as biomarkers of
Rhythmicity & HPA Reactivity
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behavioural, neuroendocrine and sleep parameters may reveal
molecular pathways that ultimately lead to the discovery of new
targets for antidepressant drugs tailored to match specific
pathologies within MD.
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